SS
GMAB icon

Steve Schonfeld’s Genmab GMAB Stock Holding History

Steve Schonfeld’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88M Buy
141,353
+127,886
+950% +$3.4M 0.01% 753
2026
Q1 		$361K Buy
+13,467
New +$404K ﹤0.01% 1504
2025
Q2 		– Sell
-10,589
Closed -$207K – 2222
2025
Q1 		$207K Buy
+10,589
New +$222K ﹤0.01% 1936
2023
Q4 		– Sell
-226,802
Closed -$8M – 2009
2023
Q3 		$8M Buy
+226,802
New +$8.64M 0.06% 409
2022
Q4 		– Sell
-246,828
Closed -$7.93M – 2756
2022
Q3 		$7.93M Buy
246,828
+36,090
+17% +$1.27M 0.07% 380
2022
Q2 		$6.85M Buy
210,738
+117,628
+126% +$3.81M 0.07% 373
2022
Q1 		$3.37M Buy
93,110
+2,739
+3% +$94K 0.03% 555
2021
Q4 		$3.57M Sell
90,371
-41,098
-31% -$1.71M 0.03% 553
2021
Q3 		$5.75M Buy
131,469
+51,019
+63% +$2.29M 0.06% 395
2021
Q2 		$3.28M Sell
80,450
-70,183
-47% -$2.71M 0.03% 565
2021
Q1 		$4.95M Buy
150,633
+63,874
+74% +$2.4M 0.06% 429
2020
Q4 		$3.53M Sell
86,759
-1,009
-1% -$37.7K 0.05% 477
2020
Q3 		$3.21M Buy
87,768
+46,213
+111% +$1.67M 0.06% 390
2020
Q2 		$1.41M Buy
41,555
+6,247
+18% +$170K 0.04% 507
2020
Q1 		$748K Sell
35,308
-67,092
-66% -$1.5M 0.05% 459
2019
Q4 		$2.29M Sell
102,400
-161,645
-61% -$3.53M 0.06% 317
2019
Q3 		$5.35M Buy
+264,045
New +$5.2M 0.16% 166

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steve Schonfeld's GMAB Position: Q2 2026 in Review

Steve Schonfeld increased its Genmab (GMAB) stake by 950% in Q2 2026, buying an estimated $3.4M and bringing the position to 141,353 shares worth $3.88M. The position accounts for 0.01% of the portfolio, ranked #753.

Steve Schonfeld first reported a position in GMAB in Q3 2019 and has held it in 17 quarters since. The position peaked at $8M in Q3 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Steve Schonfeld held 141,353 shares of Genmab worth $3.88M as of Q2 2026.
  • Steve Schonfeld bought 127,886 Genmab shares in Q2 2026, an estimated $3.4M.
  • Genmab made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #753 holding.
  • Steve Schonfeld first reported a position in Genmab in Q3 2019 and has held it in 17 quarters since.
  • Steve Schonfeld's Genmab position peaked at $8M in Q3 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.